Elevated body mass index predicts for longer overall survival duration in men with metastatic hormone-refractory prostate cancer

被引：23

作者：

Halabi, S ^{[1
]}

Small, EJ

Vogelzang, NJ

机构：

[1] Dept Biostat & Bioinformat, Durham, NC USA

[2] CALGB Stat Ctr, Durham, NC USA

[3] Univ Calif San Francisco, Urol Oncol Program, San Francisco, CA 94143 USA

[4] Nevada Canc Inst, Las Vegas, NV USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 10期

关键词：

D O I：

10.1200/JCO.2005.05.890

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2434 / 2435

页数：2

共 4 条

[1] Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy [J].

Amling, CL ;

Riffenburgh, RH ;

Sun, L ;

Moul, JW ;

Lance, RS ;

Kusuda, L ;

Sexton, WJ ;

Soderdahl, DW ;

Donahue, TF ;

Foley, JP ;

Chung, AK ;

McLeod, DG .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :439-445

[2] Overweight, obesity, and mortality from cancer in a prospectively studied cohort of US adults [J].

Calle, EE ;

Rodriguez, C ;

Walker-Thurmond, K ;

Thun, MJ .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (17) :1625-1638

[3] Impact of obesity on biochemical control after radical prostatectomy for clinically localized prostate cancer: A report by the shared equal access regional cancer hospital database study group [J].

Freedland, SJ ;

Aronson, WJ ;

Kane, CJ ;

Presti, JC ;

Amling, CL ;

Elashoff, D ;

Terris, MK .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (03) :446-453

[4] Prognostic model for predicting survival in men with hormone-refractory metastatic prostate cancer [J].

Halabi, S ;

Small, EJ ;

Kantoff, PW ;

Kattan, MW ;

Kaplan, EB ;

Dawson, NA ;

Levine, EG ;

Blumenstein, BA ;

Vogelzang, NJ .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (07) :1232-1237

← 1 →